NEW YORK (GenomeWeb News) – The chairman of the US Senate Judiciary Committee has asked National Institutes of Health Director Francis Collins to invoke a provision in federal law, which has never been used before, to license out Myriad Genetic's BRCA 1 and BRCA 2 gene patents.

Sen. Patrick Leahy (D-Vt.) last week sent a letter to Collins asking him to consider use of the so-called march-in rights under the Bayh-Dole Act "to ensure greater access to genetic testing for breast and ovarian cancer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.